We are live on ! Find out more
CCM

Conway Capital Management Portfolio holdings

AUM $214M
1-Year Est. Return 22.99%
This Fund
S&P 500
This Quarter Est. Return
-24.4%
1 Year Est. Return
+22.99%
3 Year Est. Return
+154.44%
5 Year Est. Return
+213.32%
10 Year Est. Return
AUM
$112M
AUM Growth
-$44.3M
Cap. Flow
-$3.37M
Cap. Flow %
-3.02%
Top 10 Hldgs %
69.06%
Holding
63
New
4
Increased
16
Reduced
18
Closed
14

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$1.15M
2
META icon
Meta Platforms (Facebook)
META
+$1.08M
3
COST icon
Costco
COST
+$974K
4
DECK icon
Deckers Outdoor
DECK
+$831K
5
BX icon
Blackstone
BX
+$546K

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.76M
2
CRWD icon
CrowdStrike
CRWD
+$1.04M
3
NFLX icon
Netflix
NFLX
+$829K
4
INTU icon
Intuit
INTU
+$694K
5
TSCO icon
Tractor Supply
TSCO
+$492K

Sector Composition

Rank Sector Weight
1 Technology 31.31%
2 Consumer Discretionary 28.81%
3 Communication Services 11.97%
4 Financials 9.49%
5 Healthcare 8.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NKE icon
26
Nike
NKE
$63.3B
$1.03M 0.92%
10,068
+950
+10% +$112K
DECK icon
27
Deckers Outdoor
DECK
$13.6B
$1.02M 0.91%
23,910
+19,050
+392% +$831K
ISRG icon
28
Intuitive Surgical
ISRG
$135B
$852K 0.76%
4,244
-160
-4% -$37.5K
STE icon
29
Steris
STE
$22.7B
$733K 0.66%
3,556
+2
+0.1% +$451
VEEV icon
30
Veeva Systems
VEEV
$33.5B
$526K 0.47%
2,655
-1,650
-38% -$304K
IRTC icon
31
iRhythm Holdings
IRTC
$4.1B
$459K 0.41%
4,250
+210
+5% +$27.8K
RPRX icon
32
Royalty Pharma
RPRX
$25.3B
$456K 0.41%
10,835
+10
+0.1% +$410
BKNG icon
33
Booking.com
BKNG
$149B
$408K 0.36%
5,825
-250
-4% -$21.3K
RMD icon
34
ResMed
RMD
$31.2B
$398K 0.36%
+1,900
New +$404K
SHOP icon
35
Shopify
SHOP
$152B
$397K 0.36%
12,700
-440
-3% -$18.8K
ANSS
36
DELISTED
Ansys
ANSS
$317K 0.28%
1,325
XYZ
37
Block Inc
XYZ
$48.9B
$285K 0.26%
4,645
JNJ icon
38
Johnson & Johnson
JNJ
$613B
$280K 0.25%
1,575
CRM icon
39
Salesforce
CRM
$152B
$276K 0.25%
1,675
-685
-29% -$121K
RL icon
40
Ralph Lauren
RL
$22.6B
$267K 0.24%
2,975
-3,426
-54% -$346K
EQIX icon
41
Equinix
EQIX
$102B
$260K 0.23%
395
-300
-43% -$208K
AMGN icon
42
Amgen
AMGN
$204B
$231K 0.21%
951
TMO icon
43
Thermo Fisher Scientific
TMO
$213B
$231K 0.21%
425
PARA
44
DELISTED
Paramount Global Class B
PARA
$228K 0.2%
9,250
-2,450
-21% -$74.7K
ALGN icon
45
Align Technology
ALGN
$12.4B
$213K 0.19%
+900
New +$277K
HD icon
46
Home Depot
HD
$339B
$202K 0.18%
+736
New +$217K
OLMA icon
47
Olema Pharmaceuticals
OLMA
$985M
$108K 0.1%
26,500
AMRS
48
DELISTED
Amyris Inc.
AMRS
$37K 0.03%
+20,000
New +$58.9K
GEVO icon
49
Gevo
GEVO
$355M
$29.4K 0.03%
12,500
BILL icon
50
BILL Holdings
BILL
$4.7B
-1,525
Closed -$346K

Similar funds

Conway Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Conway Capital Management held 63 positions worth $112M, down 28% from $156M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Conway Capital Management withdrew a net $3.37M in Q2 2022, closing 14 positions and reducing 18 holdings. Its most notable exit was CrowdStrike, an estimated $1.04M position sold in full.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 34% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Conway Capital Management opened a new position in ResMed worth $398K.

  • Conway Capital Management's largest Q2 2022 buy was ResMed: 1,900 shares worth $398K.
  • Conway Capital Management added most to Walt Disney in Q2 2022, an estimated $1.15M increase.
  • Conway Capital Management's biggest Q2 2022 reduction was NVIDIA, cutting an estimated $1.76M.
  • Conway Capital Management fully exited CrowdStrike in Q2 2022, selling an estimated $1.04M.
  • Conway Capital Management's ten largest holdings make up 69% of its $112M portfolio in Q2 2022.
  • Conway Capital Management opened 4 new positions and closed 14 in Q2 2022.
  • Conway Capital Management's portfolio value fell 28% quarter-over-quarter to $112M.

Based on Conway Capital Management's 13F filing for Q2 2022, filed 3 Dec 2024.